Loading…

Loading grant details…

Active PROJECT GRANT Swedish Research Council

Laser-assisted manufacturing of a catheter with a graphene-based antibacterial surface

30M kr SEK

Funder Vinnova
Recipient Organization Unknown
Country Sweden
Start Date Apr 01, 2024
End Date Sep 30, 2026
Duration 912 days
Number of Grantees 1
Roles Principal Investigator
Data Source Swedish Research Council
Grant ID 2023-04134_Vinnova
Grant Description

Purpose and goal:

Healthcare-associated infections (HAIs) is a global problem that cause a lot of suffering, high costs for healthcare and an increased risk of the spread of antibiotic resistance. The majority of HAIs are associated with the use of invasive medical devices that are colonized by bacteria, a problem that could be reduced if the product is provided with an antibacterial surface.

The goal of the project is to develop a laser-based process to create an antibacterial surface based on graphene, and to make a prototype catheter that can be used to evaluate the clinical and commercial potential. Expected results and effects:

Previous projects have demonstrated that a surface with upright graphene flakes very effectively prevents bacterial colonization. This is because the graphene flakes make it difficult for bacteria to attach to the surface and they can also puncture bacteria that try. The graphene surface has to be active against most types of bacteria including antibiotic-resistant strains and without inducing resistance as it only prevents colonization.

Prototype catheters developed in this project are expected to provide answers to the clinical and commercial potential of the technology. Approach and implementation:

Samples with antibacterial surfaces of graphene are produced by researchers at the Mid Sweden University with support from Cobolt (WP1). The antibacterial effect and other properties of the surfaces are evaluated at Chalmers and Wellspect (WP2). The process must also be adapted for a catheter surface so that a prototype can be produced and its properties evaluated under the guidance of Wellspect (WP3).

Finally, the clinical and commercial potential of the product and technology must be evaluated (WP3), and utilization and communication of the results organized (WP4).

All Grantees

Unknown

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant